Just presented our story on #KupfferCells #liver & #microplastics togehter with @mariafviola.bsky.social in the basic science session @ #EASL2025 in #Amsterdam. Great format to promote ECRs and for fantastic discussions with scientists and clinicians!
May 7, 2025 at 10:09 AM
Just presented our story on #KupfferCells #liver & #microplastics togehter with @mariafviola.bsky.social in the basic science session @ #EASL2025 in #Amsterdam. Great format to promote ECRs and for fantastic discussions with scientists and clinicians!
🚀 Heading to #EASL2025 in Amsterdam next week!
While the spotlight is on liver research, I’m excited to talk data:
📁 #FAIRdata
📊 #DataInfrastructure
🧾 #CRFdesign
⚙️ Data cleaning & QC automation
While the spotlight is on liver research, I’m excited to talk data:
📁 #FAIRdata
📊 #DataInfrastructure
🧾 #CRFdesign
⚙️ Data cleaning & QC automation
May 4, 2025 at 3:39 PM
🚀 Heading to #EASL2025 in Amsterdam next week!
While the spotlight is on liver research, I’m excited to talk data:
📁 #FAIRdata
📊 #DataInfrastructure
🧾 #CRFdesign
⚙️ Data cleaning & QC automation
While the spotlight is on liver research, I’m excited to talk data:
📁 #FAIRdata
📊 #DataInfrastructure
🧾 #CRFdesign
⚙️ Data cleaning & QC automation
Short on time? Our visual summary highlights key insights from #EASL2025 on the AATD liver care journey, designed to fit into your busy schedule. Download now for the updates you need to know on detection, care pathways, and emerging therapies #MedSky #LiverSky
ow.ly/maZ850XCIrT
ow.ly/maZ850XCIrT
December 5, 2025 at 12:34 PM
Short on time? Our visual summary highlights key insights from #EASL2025 on the AATD liver care journey, designed to fit into your busy schedule. Download now for the updates you need to know on detection, care pathways, and emerging therapies #MedSky #LiverSky
ow.ly/maZ850XCIrT
ow.ly/maZ850XCIrT
Short on time? Catch up on advances in AATD liver care relevant to your clinical practice from #EASL2025 with our NEW visual summary. For key points on detection and care pathways, plus emerging therapies at a glance, download our infographic today #MedSky #LiverSky
ow.ly/oAWW50XgYX5
ow.ly/oAWW50XgYX5
October 23, 2025 at 3:10 PM
Short on time? Catch up on advances in AATD liver care relevant to your clinical practice from #EASL2025 with our NEW visual summary. For key points on detection and care pathways, plus emerging therapies at a glance, download our infographic today #MedSky #LiverSky
ow.ly/oAWW50XgYX5
ow.ly/oAWW50XgYX5
How can multidisciplinary care improve outcomes for AATD-associated liver disease? Alice Turner shares her pulmonology perspective and how lung management basics can enhance treatment in this accredited symposium from #EASL2025 #MedSky #LiverSky
ow.ly/mgjN50Wocfc
ow.ly/mgjN50Wocfc
July 18, 2025 at 9:01 AM
How can multidisciplinary care improve outcomes for AATD-associated liver disease? Alice Turner shares her pulmonology perspective and how lung management basics can enhance treatment in this accredited symposium from #EASL2025 #MedSky #LiverSky
ow.ly/mgjN50Wocfc
ow.ly/mgjN50Wocfc
With AATD-associated liver disease, symptom-free doesn’t always mean disease-free. Get the latest updates you need to know on managing and diagnosing AATD-associated liver disease from #EASL2025 and earn #CME credit now with Medthority #MedSky #LiverSky
ow.ly/EXXP50Wn4jL
ow.ly/EXXP50Wn4jL
July 9, 2025 at 2:50 PM
With AATD-associated liver disease, symptom-free doesn’t always mean disease-free. Get the latest updates you need to know on managing and diagnosing AATD-associated liver disease from #EASL2025 and earn #CME credit now with Medthority #MedSky #LiverSky
ow.ly/EXXP50Wn4jL
ow.ly/EXXP50Wn4jL
Earn 1 #CME credit with expert insights on AATD-associated liver disease from #EASL2025. Watch the accredited symposium, led by Rohit Loomba, to get the latest updates on the Pi*ZZ genotype, emerging therapies, and the real patient experience #MedSky #MedEd #LiverSky
ow.ly/9TyM50WcojC
ow.ly/9TyM50WcojC
June 19, 2025 at 3:32 PM
hepatosight™ is rolling out across SW England, serving 6 million people, enabling early detection of liver disease, and facilitating faster clinical trial recruitment for urgently needed new treatments.
Meet our team at EASL next week to discuss.
#EASL2025 #LiverDisease #ClinicalResearch
Meet our team at EASL next week to discuss.
#EASL2025 #LiverDisease #ClinicalResearch
May 1, 2025 at 10:43 AM
hepatosight™ is rolling out across SW England, serving 6 million people, enabling early detection of liver disease, and facilitating faster clinical trial recruitment for urgently needed new treatments.
Meet our team at EASL next week to discuss.
#EASL2025 #LiverDisease #ClinicalResearch
Meet our team at EASL next week to discuss.
#EASL2025 #LiverDisease #ClinicalResearch
Meet our Medical Director, @timjobson.bsky.social, at #EASL2025 in Amsterdam!
Tim is keen to connect on advancing liver health, early diagnosis through case-finding, and innovation in healthcare.
Do reach out if you’re attending!
🌍 #LiverDisease
Tim is keen to connect on advancing liver health, early diagnosis through case-finding, and innovation in healthcare.
Do reach out if you’re attending!
🌍 #LiverDisease
April 24, 2025 at 7:15 AM
Meet our Medical Director, @timjobson.bsky.social, at #EASL2025 in Amsterdam!
Tim is keen to connect on advancing liver health, early diagnosis through case-finding, and innovation in healthcare.
Do reach out if you’re attending!
🌍 #LiverDisease
Tim is keen to connect on advancing liver health, early diagnosis through case-finding, and innovation in healthcare.
Do reach out if you’re attending!
🌍 #LiverDisease
Some of our Motion team members are currently at #EASL2025 in Amsterdam — proudly representing our deep expertise in liver research and innovation. Come say hi if you're around! 👋
#MotionTeam #EASL2025 #LiverResearch #Innovation #ProudToRepresent
#MotionTeam #EASL2025 #LiverResearch #Innovation #ProudToRepresent
May 8, 2025 at 12:10 PM
Some of our Motion team members are currently at #EASL2025 in Amsterdam — proudly representing our deep expertise in liver research and innovation. Come say hi if you're around! 👋
#MotionTeam #EASL2025 #LiverResearch #Innovation #ProudToRepresent
#MotionTeam #EASL2025 #LiverResearch #Innovation #ProudToRepresent
Can’t wait for #EASL2025! @easlnews.bsky.social
Join Colm O’Rourke and me, on Friday for a session we’ve designed and are thrilled to chair:
“Do’s and Don’ts in Liver Transcriptomics”
Arnold Room | 3–4PM
Come for insights, tips & tricks from Neil Henderson, Johan Ankarklev, & Simon Cockell!
Join Colm O’Rourke and me, on Friday for a session we’ve designed and are thrilled to chair:
“Do’s and Don’ts in Liver Transcriptomics”
Arnold Room | 3–4PM
Come for insights, tips & tricks from Neil Henderson, Johan Ankarklev, & Simon Cockell!
May 7, 2025 at 10:15 AM
Can’t wait for #EASL2025! @easlnews.bsky.social
Join Colm O’Rourke and me, on Friday for a session we’ve designed and are thrilled to chair:
“Do’s and Don’ts in Liver Transcriptomics”
Arnold Room | 3–4PM
Come for insights, tips & tricks from Neil Henderson, Johan Ankarklev, & Simon Cockell!
Join Colm O’Rourke and me, on Friday for a session we’ve designed and are thrilled to chair:
“Do’s and Don’ts in Liver Transcriptomics”
Arnold Room | 3–4PM
Come for insights, tips & tricks from Neil Henderson, Johan Ankarklev, & Simon Cockell!
Great talk by Frederike Krus on the hepatic Leptin clearance in #ACLF at the poster tour. #EASLCongress #EASL2025
May 10, 2025 at 8:37 AM
Great talk by Frederike Krus on the hepatic Leptin clearance in #ACLF at the poster tour. #EASLCongress #EASL2025
Hendrik Rogge presents his poster on circulatory failure prediction in #ACLF patients. #EASLCongress #EASL2025
May 9, 2025 at 12:24 PM
Hendrik Rogge presents his poster on circulatory failure prediction in #ACLF patients. #EASLCongress #EASL2025
Is Leptin involved in progression of #ChronicLiverDisease to #ACLF? Find it out at poster FRI-175 from Frederike Krus. #EASLCongress #EASL2025
May 9, 2025 at 12:23 PM
Is Leptin involved in progression of #ChronicLiverDisease to #ACLF? Find it out at poster FRI-175 from Frederike Krus. #EASLCongress #EASL2025
Come and visit Max Brol's poster FRI-493 at lunchtime today. #EASLCongress #EASL2025
May 9, 2025 at 9:27 AM
Come and visit Max Brol's poster FRI-493 at lunchtime today. #EASLCongress #EASL2025
Lively discussions at Max Brol's poster on the beneficial role of MFAP4 inhibition in steatotic #LiverDisease at #EASLCongress. #EASL2025
May 9, 2025 at 8:06 AM
Lively discussions at Max Brol's poster on the beneficial role of MFAP4 inhibition in steatotic #LiverDisease at #EASLCongress. #EASL2025
Yes! And #SharedDecisionMaking is something we need to educate physicians & #HBV patients on.
👉We have to be very intentional about the process, present options &
ask patients what is important to them.
I am often surprised & realize I can’t assume!
#EASL2025
notputtingonashirt.org/2019/11/21/s...
👉We have to be very intentional about the process, present options &
ask patients what is important to them.
I am often surprised & realize I can’t assume!
#EASL2025
notputtingonashirt.org/2019/11/21/s...
May 10, 2025 at 4:30 PM
Yes! And #SharedDecisionMaking is something we need to educate physicians & #HBV patients on.
👉We have to be very intentional about the process, present options &
ask patients what is important to them.
I am often surprised & realize I can’t assume!
#EASL2025
notputtingonashirt.org/2019/11/21/s...
👉We have to be very intentional about the process, present options &
ask patients what is important to them.
I am often surprised & realize I can’t assume!
#EASL2025
notputtingonashirt.org/2019/11/21/s...
Kicking off #EASL2025 with our poster on HCV microelimination in Croatian prisons! Civil society-led, mobile, and linked-to-care: The Hepatos Project is reaching where care is most needed.
#EASL2025 #EASLcongress @easlnews.bsky.social
#EASL2025 #EASLcongress @easlnews.bsky.social
May 7, 2025 at 12:12 PM
Kicking off #EASL2025 with our poster on HCV microelimination in Croatian prisons! Civil society-led, mobile, and linked-to-care: The Hepatos Project is reaching where care is most needed.
#EASL2025 #EASLcongress @easlnews.bsky.social
#EASL2025 #EASLcongress @easlnews.bsky.social
At #EASL2025, ELPA President Marko Korenjak presented 3 EU projects: A-TANGO, LIVER AIM & THRIVE.
At the Layperson Events, science met real stories — patients at the center of innovation, action & hope.
@liveraim.bsky.social @A-TANGO @THRIVE @korenjak.bsky.social @ninadonner.bsky.social
At the Layperson Events, science met real stories — patients at the center of innovation, action & hope.
@liveraim.bsky.social @A-TANGO @THRIVE @korenjak.bsky.social @ninadonner.bsky.social
May 12, 2025 at 6:51 AM
At #EASL2025, ELPA President Marko Korenjak presented 3 EU projects: A-TANGO, LIVER AIM & THRIVE.
At the Layperson Events, science met real stories — patients at the center of innovation, action & hope.
@liveraim.bsky.social @A-TANGO @THRIVE @korenjak.bsky.social @ninadonner.bsky.social
At the Layperson Events, science met real stories — patients at the center of innovation, action & hope.
@liveraim.bsky.social @A-TANGO @THRIVE @korenjak.bsky.social @ninadonner.bsky.social
Ready to turn knowledge into power?
Join us under the blue sky of Amsterdam at the #EASL2025 Layperson Event
May 7 | 14:00–15:00 CEST | Room D202
Together with @ELPA\_Europe & @ATANGO, we're bringing liver science closer to YOU – patients, caregivers, advocates.
Empower. Engage. Inspire.
Join us under the blue sky of Amsterdam at the #EASL2025 Layperson Event
May 7 | 14:00–15:00 CEST | Room D202
Together with @ELPA\_Europe & @ATANGO, we're bringing liver science closer to YOU – patients, caregivers, advocates.
Empower. Engage. Inspire.
May 5, 2025 at 9:29 AM
Ready to turn knowledge into power?
Join us under the blue sky of Amsterdam at the #EASL2025 Layperson Event
May 7 | 14:00–15:00 CEST | Room D202
Together with @ELPA\_Europe & @ATANGO, we're bringing liver science closer to YOU – patients, caregivers, advocates.
Empower. Engage. Inspire.
Join us under the blue sky of Amsterdam at the #EASL2025 Layperson Event
May 7 | 14:00–15:00 CEST | Room D202
Together with @ELPA\_Europe & @ATANGO, we're bringing liver science closer to YOU – patients, caregivers, advocates.
Empower. Engage. Inspire.
Our president, Rachel Halford speaking at the Patient and Advocate Forum at #EASLCongress.
#EASL2025
#EASL2025
May 8, 2025 at 9:28 AM
Our president, Rachel Halford speaking at the Patient and Advocate Forum at #EASLCongress.
#EASL2025
#EASL2025
At #EASLCongress? So are we! Find us just at the top of the escalators — let’s talk about how you can get involved in WHA’s activities.
🗓️ Join our #NOhep Medical Visionaries Forum
📍 Public Health Track Hub
🕓 Fri, 9 May | 16:00 CEST
#EASL2025
🗓️ Join our #NOhep Medical Visionaries Forum
📍 Public Health Track Hub
🕓 Fri, 9 May | 16:00 CEST
#EASL2025
May 7, 2025 at 11:29 AM
At #EASLCongress? So are we! Find us just at the top of the escalators — let’s talk about how you can get involved in WHA’s activities.
🗓️ Join our #NOhep Medical Visionaries Forum
📍 Public Health Track Hub
🕓 Fri, 9 May | 16:00 CEST
#EASL2025
🗓️ Join our #NOhep Medical Visionaries Forum
📍 Public Health Track Hub
🕓 Fri, 9 May | 16:00 CEST
#EASL2025
@easlnews.bsky.social #EASL2025 congress #Amsterdam
👀forward to an 🎥EASL studio on #Cirrhosis #Decompensation moderated by @debbieshawcross.bsky.social
➡️Dr.Salvador Augustin @boehringerglobal.bsky.social
➡️Dr.Katharina Staufer @genfit.bsky.social
and myself 🔗 t.ly/Ou9Wl
📅Fri 9-May-25 12.45 CEST
👀forward to an 🎥EASL studio on #Cirrhosis #Decompensation moderated by @debbieshawcross.bsky.social
➡️Dr.Salvador Augustin @boehringerglobal.bsky.social
➡️Dr.Katharina Staufer @genfit.bsky.social
and myself 🔗 t.ly/Ou9Wl
📅Fri 9-May-25 12.45 CEST
EASL Studio at EASL Congress 2025 - Promo: Decompensation and acute-on-chronic liver failure
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.
t.ly
May 2, 2025 at 9:18 PM
@easlnews.bsky.social #EASL2025 congress #Amsterdam
👀forward to an 🎥EASL studio on #Cirrhosis #Decompensation moderated by @debbieshawcross.bsky.social
➡️Dr.Salvador Augustin @boehringerglobal.bsky.social
➡️Dr.Katharina Staufer @genfit.bsky.social
and myself 🔗 t.ly/Ou9Wl
📅Fri 9-May-25 12.45 CEST
👀forward to an 🎥EASL studio on #Cirrhosis #Decompensation moderated by @debbieshawcross.bsky.social
➡️Dr.Salvador Augustin @boehringerglobal.bsky.social
➡️Dr.Katharina Staufer @genfit.bsky.social
and myself 🔗 t.ly/Ou9Wl
📅Fri 9-May-25 12.45 CEST
Honoured to to be part of this Future of Hepatology session at @easlnews.bsky.social #EASL2025, discussing the promise of #microbiome related therapies in #PSC #cholestatic liver disease - where have we come since the original #FMT #PSC pilot study by @DrAllegrettiIBD? doi.org/10.14309/ajg...
May 10, 2025 at 6:33 AM
Honoured to to be part of this Future of Hepatology session at @easlnews.bsky.social #EASL2025, discussing the promise of #microbiome related therapies in #PSC #cholestatic liver disease - where have we come since the original #FMT #PSC pilot study by @DrAllegrettiIBD? doi.org/10.14309/ajg...
The session wraps up with Naim Alkhouri presenting results from the NAVIGATE trial of 2mg/kg, 4mg/kg belapectin or pbo in MASH cirrhosis with portal hypertension (n=~120 per arm) #EASLCirrhosis
May 10, 2025 at 12:30 PM